LON: IDHC Statistics

Total Valuation

Integrated Diagnostics Holdings has a market cap or net worth of GBP 208.07 million. The enterprise value is 220.41 million.

Market Cap	208.07M
Enterprise Value	220.41M

Important Dates

The next estimated earnings date is Thursday, April 3, 2025.

Earnings Date	Apr 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Integrated Diagnostics Holdings has 581.33 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	581.33M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	27.57%
Owned by Institutions (%)	22.20%
Float	258.13M

Valuation Ratios

The trailing PE ratio is 15.87 and the forward PE ratio is 16.48.

PE Ratio	15.87
Forward PE	16.48
PS Ratio	2.73
PB Ratio	4.65
P/TBV Ratio	12.60
P/FCF Ratio	20.73
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.66, with an EV/FCF ratio of 21.95.

EV / Earnings	16.37
EV / Sales	2.80
EV / EBITDA	9.66
EV / EBIT	14.03
EV / FCF	21.95

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.36.

Current Ratio	1.59
Quick Ratio	1.28
Debt / Equity	0.36
Debt / EBITDA	0.92
Debt / FCF	2.09
Interest Coverage	6.34

Financial Efficiency

Return on equity (ROE) is 23.03% and return on invested capital (ROIC) is 13.46%.

Return on Equity (ROE)	23.03%
Return on Assets (ROA)	9.69%
Return on Capital (ROIC)	13.46%
Revenue Per Employee	11,690
Profits Per Employee	2,012
Employee Count	6,692
Asset Turnover	0.78
Inventory Turnover	7.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.13% in the last 52 weeks. The beta is 0.59, so Integrated Diagnostics Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+16.13%
50-Day Moving Average	0.44
200-Day Moving Average	0.37
Relative Strength Index (RSI)	56.25
Average Volume (20 Days)	114,682

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Integrated Diagnostics Holdings had revenue of GBP 78.23 million and earned 13.46 million in profits. Earnings per share was 0.02.

Revenue	78.23M
Gross Profit	29.51M
Operating Income	15.63M
Pretax Income	18.37M
Net Income	13.46M
EBITDA	20.22M
EBIT	15.63M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 21.32 million in cash and 20.98 million in debt, giving a net cash position of 339,710 or 0.00 per share.

Cash & Cash Equivalents	21.32M
Total Debt	20.98M
Net Cash	339,710
Net Cash Per Share	0.00
Equity (Book Value)	58.52M
Book Value Per Share	0.08
Working Capital	16.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.82 million and capital expenditures -3.78 million, giving a free cash flow of 10.04 million.

Operating Cash Flow	13.82M
Capital Expenditures	-3.78M
Free Cash Flow	10.04M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 37.72%, with operating and profit margins of 19.98% and 17.21%.

Gross Margin	37.72%
Operating Margin	19.98%
Pretax Margin	23.49%
Profit Margin	17.21%
EBITDA Margin	25.85%
EBIT Margin	19.98%
FCF Margin	12.83%

Dividends & Yields

Integrated Diagnostics Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on December 24, 2020. It was a forward split with a ratio of 4.

Last Split Date	Dec 24, 2020
Split Type	Forward
Split Ratio	4

Scores

Integrated Diagnostics Holdings has an Altman Z-Score of 3.28.

Altman Z-Score	3.28
Piotroski F-Score	n/a